Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Francis DuhayDirector | enVVeno MedicalNVNO | Open-market sale10b5-1 plan | 06/11 | 06/12 | 140 sh | $10.31 | $1,443.4 | −5.6% |
Francis DuhayDirector | enVVeno MedicalNVNO | Open-market sale10b5-1 plan | 03/12 | 03/13 | 140 sh | $11.52 | $1,612.8 | −5.3% |
Francis DuhayDirector | enVVeno MedicalNVNO | Open-market sale10b5-1 plan | 25/12/11 | 25/12/12 | 4,900 sh | $0.36 | $1,764 | −5.0% |
Francis DuhayDirector | enVVeno MedicalNVNO | Open-market sale10b5-1 plan | 25/09/15 | 25/09/17 | 4,900 sh | $0.83 | $4,067 | −4.8% |
Francis DuhayDirector | enVVeno MedicalNVNO | Open-market buy | 24/12/31 | 25/01/03 | 81,433 sh | $3.07 | $249,999.31 | +389.4% |
Robert GrayDirector | enVVeno MedicalNVNO | Open-market buy | 24/12/31 | 25/01/02 | 3,500 sh | $2.94 | $10,290 | +45.7% |
Sanjay ShrivastavaDirector | enVVeno MedicalNVNO | Open-market buy | 24/12/24 | 24/12/26 | 5,400 sh | $2.90 | $15,660 | +138.9% |
Matthew JenusaitisDirector | enVVeno MedicalNVNO | Open-market buy | 24/12/19 | 24/12/23 | 9,620 sh | $2.53 | $24,338.6 | +138.9% |
enVVeno MedicalNVNO | Open-market buy | 24/12/19 | 24/12/19 | 12,000 sh | $2.55 | $30,600 | +5.7% | |
Hamed AlaviCTO | enVVeno MedicalNVNO | Open-market sale | 24/03/13 | 24/03/15 | 8,334 sh | $6.22 | $51,837.48 | −100.0% |